Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1

다국어 초록 (Multilingual Abstract)

The Hsp90 family proteins Hsp90, Grp94, and TRAP1 are present in the cell cytoplasm, endoplasmic reticulum, and mitochondria, respectively; all play important roles in tumorigenesis by regulating protein homeostasis in response to stress. Thus, simultaneous inhibition of all Hsp90 paralogs is a reasonable strategy for cancer therapy. However, since the existing pan-Hsp90 inhibitor does not accumulate in mitochondria, the potential anticancer activity of pan-Hsp90 inhibition has not yet been fully examined in vivo. Analysis of The Cancer Genome Atlas database revealed that all Hsp90 paralogs were upregulated in prostate cancer. Inactivation of all Hsp90 paralogs induced mitochondrial dysfunction, increased cytosolic calcium, and activated calcineurin. Active calcineurin blocked prosurvival heat shock responses upon Hsp90 inhibition by preventing nuclear translocation of HSF1. The purine scaffold derivative DN401 inhibited all Hsp90 paralogs simultaneously and showed stronger anticancer activity than other Hsp90 inhibitors. PanHsp90 inhibition increased cytotoxicity and suppressed mechanisms that protect cancer cells, suggesting that it is a feasible strategy for the development of potent anticancer drugs. The mitochondria-permeable drug DN401 is a newly identified in vivo pan-Hsp90 inhibitor with potent anticancer activity.

참고문헌 (Reference)

1 Sorger, P. K., "Yeast heat shock factor is an essential DNAbinding protein that exhibits temperature-dependent phosphorylation" 54 : 855-864, 1988

2 Hogan, P. G., "Transcriptional regulation by calcium, calcineurin, and NFAT" 17 : 2205-2232, 2003

3 Rao, A., "Transcription factors of the NFAT family : regulation and function" 15 : 707-747, 1997

4 Meldolesi, J., "The endoplasmic reticulumCa2+ store : a view from the lumen" 23 : 10-14, 1998

5 Masgras, I., "The chaperone TRAP1as a modulator of the mitochondrial adaptations in cancer cells" 7 : 58-, 2017

6 Schopf, F. H., "The HSP90 chaperone machinery" 18 : 345-360, 2017

7 Trepel, J., "Targeting the dynamic HSP90 complex in cancer" 10 : 537-, 2010

8 Chatterjee, S., "Targeting heat shock proteins in cancer : a promising therapeutic approach" 18 : 1978-, 2017

9 Chen, Y., "Targeting HSF1 sensitizes cancer cells to HSP90 inhibition" 4 : 816-, 2013

10 강병헌, "TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors" 생화학분자생물학회 45 (45): 1-6, 2012

11 Schett, G., "TNFα mediates susceptibility to heat-induced apoptosis by protein phosphatase-mediated inhibition of the HSF1/hsp70 stress response" 10 : 1126-, 2003

12 Bechard, M., "Subcellular localization of glycogen synthase kinase 3β controls embryonic stem cell self-renewal" 29 : 2092-2104, 2009

13 Soncin, F., "Role of calcium activated kinases and phosphatases in heat shock factor-1 activation" 6 : 705-710, 2000

14 Zou, J., "Repression of heat shock transcription factor HSF1 activation by HSP90(HSP90 complex)that forms a stress-sensitive complex with HSF1" 94 : 471-480, 1998

15 Kang, B. H., "Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network" 131 : 257-270, 2007

16 Pratt, W. B., "Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery" 228 : 111-133, 2003

17 Wang, X., "Regulation of molecular chaperone gene transcription involves the serine phosphorylation, 14-3-3 epsilon binding, and cytoplasmic sequestration of heat shock factor 1" 23 : 6013-6026, 2003

18 Xiao, Y., "Recent advances in the discovery of novel HSP90 inhibitors:an update from 2014" 2019

19 Murshid, A., "Protein kinase A binds and activates heat shock factor 1" 5 : e13830-, 2010

20 Bhat, R., "Progress in the discovery and development of heat shock protein 90(Hsp90)inhibitors : miniperspective" 57 : 8718-8728, 2014

21 Patel, P. D., "Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2" 9 : 677-, 2013

22 Park, H. -K., "Paralog specificity determines subcellular distribution, action mechanism, and anticancer activity of TRAP1 inhibitors" 60 : 7569-7578, 2017

23 Shou, J., "Nuclear factor of activated T cells in cancer development and treatment" 361 : 174-184, 2015

24 Müller, M. R., "NFAT, immunity and cancer: a transcription factor comes of age" 10 : 645-, 2010

25 Conde, R., "Modulation of Hsf1activity by novobiocin and geldanamycin" 87 : 845-851, 2009

26 Youle, R. J., "Mitochondrial fission in apoptosis" 6 : 657-, 2005

27 Landriscina, M., "Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents" 70 : 6577-6586, 2010

28 Park, H. -K., "Mitochondrial Hsp90s suppress calcium-mediated stress signals propagating from mitochondria to the ER in cancer cells" 13 : 148-, 2014

29 Park, H. -K., "Interplay between TRAP1 and sirtuin-3 modulates mitochondrial respiration and oxidative stress to maintain stemness of glioma stem cells" 9 : 1369-1382, 2019

30 Mivechi, N. F., "Inhibitors of tyrosine and Ser/Thr phosphatases modulate the heat shock response" 54 : 186-197, 1994

31 Prodromou, C., "Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone" 90 : 65-75, 1997

32 Neckers, L., "Hsp90 inhibitors disrupt mitochondrial homeostasis in cancer cells" 14 : 1204-1206, 2007

33 Neckers, L., "Heat shock protein 90" 15 : 419-424, 2003

34 Dayalan Naidu, S., "Heat Shock Factor 1 Is a Substrate for p38 Mitogen-Activated Protein Kinases" 36 : 2403-2417, 2016

35 Koll, T. T., "HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair" 7 : 1985-1992, 2008

36 Taipale, M., "HSP90 at the hub of protein homeostasis : emerging mechanistic insights" 11 : 515-, 2010

37 Whitesell, L., "HSP90 and the chaperoning of cancer" 5 : 761-, 2005

38 Jaeger, A. M., "HSP90 : enabler of cancer adaptation" 3 : 275-297, 2019

39 Wang, X., "HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy(Review)" 45 : 18-30, 2014

40 Lee, A. S., "Glucose-regulated proteins in cancer : molecular mechanisms and therapeutic potential" 14 : 263-, 2014

41 Meijer, L., "GSK-3-selective inhibitors derived from Tyrian purple indirubins" 10 : 1255-1266, 2003

42 Guo, Y., "Evidence for a mechanism of repression of heat shock factor 1transcriptional activity by a multichaperone complex" 276 : 45791-45799, 2001

43 Funauchi, M., "Effects of an inhibitor for calcium/calmodulin-dependent protein phosphatase, calcineurin, on induction of long-term potentiation in rat visual cortex" 19 : 269-278, 1994

44 Wang, P., "Dynamin-related protein Drp1 is required for Bax translocation to mitochondria in response to irradiation-induced apoptosis" 6 : 22598-, 2015

45 Chou, T.-C., "Drug combination studies and their synergy quantification using the Chou-Talalay method" 70 : 440-446, 2010

46 Lee, C., "Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1" 137 : 4358-4367, 2015

47 Cereghetti, G., "Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria" 105 : 15803-15808, 2008

48 Kang, B. H., "Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones" 28 : 3681-, 2009

49 Cassidy-Stone, A., "Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization" 14 : 193-204, 2008

50 Mognol, G., "Cell cycle and apoptosis regulation by NFAT transcription factors : new roles for an old player" 7 : e2199-, 2016

51 Brookes, P. S., "Calcium, ATP, and ROS: a mitochondrial love-hate triangle" 287 : C817-C833, 2004

52 Guettouche, T., "Analysis of phosphorylation of human heat shock factor 1 in cells experiencing a stress" 6 : 4-, 2005

53 Jhaveri, K., "Advances in the clinical development of heat shock protein 90(Hsp90)inhibitors in cancers" 1823 : 742-755, 2012

54 Pacey, S., "A phase I study of the heat shock protein 90 inhibitor alvespimycin(17-DMAG)given intravenously to patients with advanced solid tumors" 17 : 1561-1570, 2011